The neuroprotective activity of heat-treated human platelet lysate biomaterials manufactured from outdated pathogen-reduced (amotosalen/UVA) platelet concentrates

[1]  T. Walker,et al.  Platelets: the missing link between the blood and brain? , 2019, Progress in Neurobiology.

[2]  D. Devos,et al.  Past and Future of Neurotrophic Growth Factors Therapies in ALS: From Single Neurotrophic Growth Factor to Stem Cells and Human Platelet Lysates , 2019, Front. Neurol..

[3]  Yu-ting Su,et al.  A double‐virally‐inactivated (Intercept–solvent/detergent) human platelet lysate for in vitro expansion of human mesenchymal stromal cells , 2019, Transfusion.

[4]  R. Henschler,et al.  Human platelet lysate current standards and future developments , 2019, Transfusion.

[5]  Hsiu-Chen Lin,et al.  Four types of human platelet lysate, including one virally inactivated by solvent-detergent, can be used to propagate Wharton jelly mesenchymal stromal cells. , 2019, New biotechnology.

[6]  G. Kempermann,et al.  Exercise-Induced Activated Platelets Increase Adult Hippocampal Precursor Proliferation and Promote Neuronal Differentiation , 2019, Stem cell reports.

[7]  L. Buée,et al.  Neuronal AMP-activated protein kinase hyper-activation induces synaptic loss by an autophagy-mediated process , 2019, Cell Death & Disease.

[8]  V. Compernolle,et al.  Biomolecular Consequences of Platelet Pathogen Inactivation Methods. , 2019, Transfusion medicine reviews.

[9]  C. Custódio,et al.  Blood Plasma Derivatives for Tissue Engineering and Regenerative Medicine Therapies. , 2018, Tissue engineering. Part B, Reviews.

[10]  W. Handke,et al.  Ultraviolet C light efficiently inactivates nonenveloped hepatitis A virus and feline calicivirus in platelet concentrates , 2018, Transfusion.

[11]  P. Sandgren,et al.  Optimized processing for pathogen inactivation of double‐dose buffy‐coat platelet concentrates: maintained in vitro quality over 7‐day storage , 2018, Vox sanguinis.

[12]  S. Habtemariam.  The brain-derived neurotrophic factor in neuronal plasticity and neuroregeneration: new pharmacological concepts for old and new drugs , 2018, Neural regeneration research.

[13]  T. Kreil.  Building blocks of the viral safety margins of industrial plasma products , 2018 .

[14]  W. Robinson,et al.  Men and Women Differ in the Biochemical Composition of Platelet-Rich Plasma , 2018, The American journal of sports medicine.

[15]  P. Sandgren.  Preserved in vitro metabolic and functional characteristics of double-dose apheresis platelet concentrates photochemically treated with amotosalen and ultraviolet A light. , 2016, Blood transfusion = Trasfusione del sangue.

[16]  R. Bordet,et al.  The protective effect of human platelet lysate in models of neurodegenerative disease: involvement of the Akt and MEK pathways , 2017, Journal of tissue engineering and regenerative medicine.

[17]  D. Devos,et al.  Tailor-made purified human platelet lysate concentrated in neurotrophins for treatment of Parkinson's disease. , 2017, Biomaterials.

[18]  L. Smirnova,et al.  3D Differentiation of LUHMES Cell Line to Study Recovery and Delayed Neurotoxic Effects , 2017, Current protocols in toxicology.

[19]  Q. Lian,et al.  Molecular mechanisms of brain-derived neurotrophic factor in neuro-protection: Recent developments , 2017, Brain Research.

[20]  J. Polesel,et al.  Standardization of platelet releasate products for clinical applications in cell therapy: a mathematical approach , 2017, Journal of Translational Medicine.

[21]  A. Bush,et al.  Ferroptosis and cell death mechanisms in Parkinson's disease , 2017, Neurochemistry International.

[22]  L. Smirnova,et al.  Characterization of three human cell line models for high‐throughput neuronal cytotoxicity screening , 2017, Journal of applied toxicology : JAT.

[23]  A. Walch,et al.  ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. , 2017, Nature chemical biology.

[24]  R. Bordet,et al.  Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC , 2016, Neurobiology of Disease.

[25]  Dirk Strunk,et al.  Human platelet lysate: Replacing fetal bovine serum as a gold standard for human cell propagation? , 2016, Biomaterials.

[26]  G. Scambia,et al.  Culture of human cell lines by a pathogen-inactivated human platelet lysate , 2016, Cytotechnology.

[27]  T. Jovin,et al.  Elevated α-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson's patient-derived induced pluripotent stem cells , 2015, Cell Death and Disease.

[28]  O. Sigurjonsson,et al.  Expired and Pathogen-Inactivated Platelet Concentrates Support Differentiation and Immunomodulation of Mesenchymal Stromal Cells in Culture , 2015, Cell transplantation.

[29]  G. Duverlie,et al.  Inactivation of viruses in platelet and plasma products using a riboflavin‐and‐UV–based photochemical treatment , 2015, Transfusion.

[30]  G. Superti-Furga,et al.  Human Haploid Cell Genetics Reveals Roles for Lipid Metabolism Genes in Nonapoptotic Cell Death , 2015, ACS chemical biology.

[31]  E. Carro,et al.  Intranasal PRGF-Endoret enhances neuronal survival and attenuates NF-κB-dependent inflammation process in a mouse model of Parkinson's disease. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[32]  N. Lion,et al.  The clinical and biological impact of new pathogen inactivation technologies on platelet concentrates. , 2014, Blood reviews.

[33]  R. Topolski,et al.  Gender and age differences in growth factor concentrations from platelet-rich plasma in adults. , 2014, Military medicine.

[34]  C. Humpel,et al.  Platelet-derived nerve growth factor supports the survival of cholinergic neurons in organotypic rat brain slices , 2014, Neuroscience Letters.

[35]  R. Nieuwland,et al.  Single-step isolation of extracellular vesicles by size-exclusion chromatography , 2014, Journal of extracellular vesicles.

[36]  M. Gawaz,et al.  Platelets in tissue repair: control of apoptosis and interactions with regenerative cells. , 2013, Blood.

[37]  J. Galipeau,et al.  The effect of platelet lysate fibrinogen on the functionality of MSCs in immunotherapy. , 2013, Biomaterials.

[38]  E. Carro,et al.  Intranasal Delivery of Plasma and Platelet Growth Factors Using PRGF-Endoret System Enhances Neurogenesis in a Mouse Model of Alzheimer’s Disease , 2013, PloS one.

[39]  O. Sigurjonsson,et al.  Platelet Lysates Produced from Expired Platelet Concentrates Support Growth and Osteogenic Differentiation of Mesenchymal Stem Cells , 2013, PloS one.

[40]  D. Varon,et al.  Platelet lysates stimulate angiogenesis, neurogenesis and neuroprotection after stroke , 2013, Thrombosis and Haemostasis.

[41]  T. Burnouf,et al.  Human platelet concentrates: a source of solvent/detergent‐treated highly enriched brain‐derived neurotrophic factor , 2012, Transfusion.

[42]  Matthew C. Phipps,et al.  Delivery of Platelet-Derived Growth Factor as a Chemotactic Factor for Mesenchymal Stem Cells by Bone-Mimetic Electrospun Scaffolds , 2012, PloS one.

[43]  M. R. Lamprecht,et al.  Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death , 2012, Cell.

[44]  Tanja Waldmann,et al.  Rapid, complete and large‐scale generation of post‐mitotic neurons from the human LUHMES cell line , 2011, Journal of neurochemistry.

[45]  T. Burnouf,et al.  A chromatographically purified human TGF‐β1 fraction from virally inactivated platelet lysates , 2011, Vox sanguinis.

[46]  M. Ahn,et al.  Individual Variation in Growth Factor Concentrations in Platelet-rich Plasma and Its Influence on Human Mesenchymal Stem Cells , 2011, The Korean journal of laboratory medicine.

[47]  Lily Lin,et al.  Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the INTERCEPT Blood SystemTM , 2011, Transfusion Medicine and Hemotherapy.

[48]  J. Simon,et al.  AMP-activated Protein Kinase Signaling Activation by Resveratrol Modulates Amyloid-β Peptide Metabolism* , 2010, The Journal of Biological Chemistry.

[49]  D. Strunk,et al.  Human Alternatives to Fetal Bovine Serum for the Expansion of Mesenchymal Stromal Cells from Bone Marrow , 2009, Stem cells.

[50]  M. Mattson,et al.  Mutant Presenilin 1 Increases the Expression and Activity of BACE1* , 2009, Journal of Biological Chemistry.

[51]  T. Burnouf.  Modern Plasma Fractionation , 2007, Transfusion Medicine Reviews.

[52]  Jeppe Falsig,et al.  Progressive Degeneration of Human Mesencephalic Neuron-Derived Cells Triggered by Dopamine-Dependent Oxidative Stress Is Dependent on the Mixed-Lineage Kinase Pathway , 2005, The Journal of Neuroscience.

[53]  J. Virchow,et al.  The impact of age, weight and gender on BDNF levels in human platelets and plasma , 2004, Neurobiology of Aging.

[54]  V. Ciaravino,et al.  The role of toxicology assessment in transfusion medicine , 2003, Transfusion.

[55]  T Burnouf,et al.  Reducing the risk of infection from plasma products: specific preventative strategies. , 2000, Blood reviews.

[56]  J. Clarke,et al.  Medicine , 1907, Bristol medico-chirurgical journal.